REPO-TRIAL COMMENCES ITS HEART FAILURE DRUG REPURPOSING TRIAL
REPO-TRIAL has randomised the first patients in REPO-HFpEF II, a Phase IIa clinical trial investigating the treatment of a type of chronic heart failure characterised by stiffness of the left ventricle. HFpEF is common in the elderly and diabetics and has no survival-prolonging treatment. Read the entire press release.